Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Vertex Pharmaceuticals Inc Transaction History

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.

$721 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2024	SELL	$283.23 - $323.1 $17.1 Million - $19.6 Million	-60,527 Closed	0 $0
Q4 2022 May 17, 2024	BUY	$285.76 - $321.48 $410,351 - $461,645	1,436 Added 2.43%	60,527 $17.5 Billion
Q3 2022 May 17, 2024	BUY	$273.83 - $305.53 $16.2 Million - $18.1 Million	59,091 New	59,091 $17.1 Billion
Q2 2020 May 17, 2024	SELL	$225.48 - $295.8 $13.9 Million - $18.2 Million	-61,500 Closed	0 $0
Q1 2020 May 17, 2024	BUY	$199.77 - $247.81 $12.3 Million - $15.2 Million	61,500 New	61,500 $14.6 Billion
Q4 2019 May 17, 2024	BUY	$166.71 - $223.91 $10.3 Million - $13.8 Million	61,500 New	61,500 $13.5 Billion

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.5 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.8 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.9 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.49 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.18 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.

Account